标题
HDAC Inhibitors: Innovative Strategies for Their Design and Applications
作者
关键词
-
出版物
MOLECULES
Volume 27, Issue 3, Pages 715
出版商
MDPI AG
发表日期
2022-01-24
DOI
10.3390/molecules27030715
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain
- (2021) Tetsuro Tago et al. ACS Chemical Neuroscience
- Spatial distribution of advanced stage diagnosis and mortality of breast cancer: Socioeconomic and health service offer inequalities in Brazil
- (2021) Nayara Priscila Dantas de Oliveira et al. PLoS One
- Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
- (2021) Robert Jenke et al. Cancers
- β-Cyclodextrin-poly (β-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors
- (2021) Sauradip Chaudhuri et al. ACS Applied Materials & Interfaces
- Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
- (2021) Laura Márquez-Cantudo et al. MOLECULES
- Novel late-stage radiosynthesis of 5-[18F]-trifluoromethyl-1,2,4-oxadiazole (TFMO) containing molecules for PET imaging
- (2021) Nashaat Turkman et al. Scientific Reports
- Direct Amidation to Access 3-Amido-1,8-Naphthalimides Including Fluorescent Scriptaid Analogues as HDAC Inhibitors
- (2021) Kyle N. Hearn et al. Cells
- Translation of HDAC6 PET Imaging Using [18F]EKZ-001–cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates
- (2020) Sofie Celen et al. ACS Chemical Neuroscience
- Polysaccharide Nanoparticles Bearing HDAC Inhibitor as Nontoxic Nanocarrier for Drug Delivery
- (2020) Henry Lindemann et al. MACROMOLECULAR BIOSCIENCE
- Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase
- (2020) Ka Yang et al. ACS Medicinal Chemistry Letters
- Hydroxamic Acids Immobilized on Resins (HAIRs): A Toolbox for the Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
- (2020) Laura Sinatra et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Environment-sensitive fluorescent inhibitors of histone deacetylase
- (2020) Xin Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Proteolysis targeting chimeras (PROTACs) for epigenetics research
- (2020) Anja Vogelmann et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain
- (2020) Michel Koole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models
- (2020) Umberto Tosi et al. Science Advances
- The design of a novel near-infrared fluorescent HDAC inhibitor and image of tumor cells
- (2020) Ying Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PROTAC: A promising technology for cancer treatment
- (2020) Xin Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biocompatible sulfated valproic acid-coupled polysaccharide-based nanocarriers with HDAC inhibitory activity
- (2020) Marie Kühne et al. JOURNAL OF CONTROLLED RELEASE
- Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)
- (2020) Fangyuan Cao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor
- (2020) Rui Han et al. Molecular Therapy-Oncolytics
- Developing potent PROTACs tools for selective degradation of HDAC6 protein
- (2019) Zixuan An et al. Protein & Cell
- Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment
- (2019) Esma Alp et al. International Journal of Nanomedicine
- Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16·F10 melanoma
- (2019) Koen Vermeulen et al. NUCLEAR MEDICINE AND BIOLOGY
- Advances in the strategies for designing receptor-targeted molecular imaging probes for cancer research
- (2019) Young Ji Ko et al. JOURNAL OF CONTROLLED RELEASE
- Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
- (2019) Hao Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Imaging HDACs In Vivo: Cross-Validation of the [11C]Martinostat Radioligand in the Pig Brain
- (2019) L. L. Donovan et al. MOLECULAR IMAGING AND BIOLOGY
- Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery
- (2019) Chu Tang et al. MOLECULAR IMAGING AND BIOLOGY
- Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications
- (2019) Yuichiro Hori et al. ACCOUNTS OF CHEMICAL RESEARCH
- Fluorescent analogs of peptoid-based HDAC inhibitors: Synthesis, biological activity and cellular uptake kinetics
- (2019) Rick Raudszus et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Evaluation of 18F-INER-1577-3 as a Central Nervous System (CNS) Histone Deacetylase Imaging Agent
- (2019) Ming- Hsin Li et al. Current Medical Imaging Reviews
- Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality
- (2019) Philip P. Chamberlain et al. ACS Medicinal Chemistry Letters
- Radiosynthesis and preliminary evaluation of an 18 F-labeled tubastatin A analog for PET imaging of histone deacetylase 6
- (2019) Tetsuro Tago et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and Evaluation of 2-[18F]Fluoroethyltriazolesuberohydroxamine Acid for Histone Deacetylase in a Tumor Model as a Positron Emission Tomography Radiotracer
- (2018) In Sun Kim et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
- (2018) Heba M. Hesham et al. MEDICINAL RESEARCH REVIEWS
- Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
- (2018) Tetsuro Tago et al. MOLECULES
- 18F-Radiolabeled Panobinostat Allows for Positron Emission Tomography Guided Delivery of a Histone Deacetylase Inhibitor
- (2018) Harikrishna Kommidi et al. ACS Medicinal Chemistry Letters
- Histone Deacetylase Inhibitors and Diabetic Kidney Disease
- (2018) Mitchell Hadden et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A highly HDAC6-selective inhibitor acts as a fluorescent probe
- (2018) Yi-Hsun Ho et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Highly fluorescent and HDAC6 selective scriptaid analogues
- (2018) Cassandra L. Fleming et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia
- (2018) Tonya M. Gilbert et al. JOURNAL OF CLINICAL INVESTIGATION
- Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment
- (2018) Chunlin Zhuang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a fluorescent probe with HDAC6 selective inhibition
- (2017) Yingjie Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
- (2017) Matthias Schiedel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers
- (2017) Raj Kumar Thapa et al. Nanomedicine-Nanotechnology Biology and Medicine
- Homing in on an intracellular target for delivery of loaded nanoparticles functionalized with a histone deacetylase inhibitor
- (2017) Jie Zhang et al. Oncotarget
- HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination
- (2017) Martin G. Strebl et al. ACS Central Science
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
- (2016) Elena Ceccacci et al. BRITISH JOURNAL OF CANCER
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Drug developers delve into the cell's trash-disposal machinery
- (2016) Kelly Rae Chi NATURE REVIEWS DRUG DISCOVERY
- Epigenetic drug discovery: breaking through the immune barrier
- (2016) David F. Tough et al. NATURE REVIEWS DRUG DISCOVERY
- Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy
- (2016) Fatima el Bahhaj et al. Theranostics
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- Modulation of Butyrate Anticancer Activity by Solid Lipid Nanoparticle Delivery: An in Vitro Investigation on Human Breast Cancer and Leukemia Cell Lines
- (2016) Federica Foglietta et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Development of a Fluorinated Class-I HDAC Radiotracer Reveals Key Chemical Determinants of Brain Penetrance
- (2015) Martin G. Strebl et al. ACS Chemical Neuroscience
- Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
- (2015) Edina C. Wang et al. BIOMATERIALS
- Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)-Induced seizures in adult Danio rerio (Zebrafish)
- (2015) Bianca A. Torres-Hernández et al. BMC Complementary and Alternative Medicine
- Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review
- (2015) R D Neal et al. BRITISH JOURNAL OF CANCER
- A fluorescent histone deacetylase (HDAC) inhibitor for cellular imaging
- (2015) Cassandra L. Fleming et al. CHEMICAL COMMUNICATIONS
- Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids
- (2015) Quaovi H. Sodji et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery
- (2015) Iza Denis et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Exploration of the labeling of [11C]tubastatin A at the hydroxamic acid site with [11C]carbon monoxide
- (2015) Shuiyu Lu et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- An HDAC-Targeted Imaging Probe LBH589–Cy5.5 for Tumor Detection and Therapy Evaluation
- (2015) Qingqing Meng et al. MOLECULAR PHARMACEUTICS
- PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread
- (2015) Xiaolong Tang et al. Nanoscale Research Letters
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics
- (2015) Hong Zong et al. ChemistryOpen
- PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread
- (2015) Xiaolong Tang et al. Nanoscale Research Letters
- Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain
- (2015) Robin Bonomi et al. PLoS One
- Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer
- (2014) Renu Sankar et al. BIOMEDICINE & PHARMACOTHERAPY
- In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs
- (2014) Changning Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neuroimaging in Parkinson disease: from research setting to clinical practice
- (2014) Marios Politis Nature Reviews Neurology
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain
- (2013) Young Jun Seo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Poster Presentation
- (2013) JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque
- (2013) Jason P. Holland et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Structural basis for molecular recognition of folic acid by folate receptors
- (2013) Chen Chen et al. NATURE
- Visualizing epigenetics: Current advances and advantages in HDAC PET imaging techniques
- (2013) C. Wang et al. NEUROSCIENCE
- Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET
- (2013) Sung Won Kim et al. NUCLEAR MEDICINE AND BIOLOGY
- Small-molecule fluorophores and fluorescent probes for bioimaging
- (2013) Takuya Terai et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Novel 64Cu-Labeled CUDC-101 for in Vivo PET Imaging of Histone Deacetylases
- (2013) Qingqing Meng et al. ACS Medicinal Chemistry Letters
- Engineering Folate–Drug Conjugates to Target Cancer: From Chemistry to Clinic
- (2012) Iontcho R. Vlahov et al. BIOCONJUGATE CHEMISTRY
- Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
- (2012) T. Ai et al. CURRENT MEDICINAL CHEMISTRY
- HDAC inhibitors in HIV
- (2011) Fiona Wightman et al. IMMUNOLOGY AND CELL BIOLOGY
- In Vivo PET Imaging of Histone Deacetylases by18F-Suberoylanilide Hydroxamic Acid (18F-SAHA)
- (2011) J. Adam Hendricks et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Folate-Hydroxamate Based Antimetabolites: Synthesis and Biological Evaluation
- (2011) Marta P. Carrasco et al. Medicinal Chemistry
- Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
- (2011) Y. Kong et al. MOLECULAR CANCER THERAPEUTICS
- The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), A PET radiotracer designed for the delineation of histone deacetylase expression in cancer
- (2011) Brian M. Zeglis et al. NUCLEAR MEDICINE AND BIOLOGY
- The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
- (2011) Lucia M. A. Crane et al. CELLULAR ONCOLOGY
- Coumarin-suberoylanilide hydroxamic acid as a fluorescent probe for determining binding affinities and off-rates of histone deacetylase inhibitors
- (2010) Raushan K. Singh et al. ANALYTICAL BIOCHEMISTRY
- Histone Deacetylase Inhibitor MS-275 Exhibits Poor Brain Penetration: Pharmacokinetic Studies of [11C]MS-275 using Positron Emission Tomography
- (2009) Jacob M. Hooker et al. ACS Chemical Neuroscience
- Histone deacetylase inhibitor prodrugs in nanoparticle vector enhanced gene expression in human cancer cells
- (2009) Yuta Ishii et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins
- (2009) Sjoerd J. L. van Wijk et al. FASEB JOURNAL
- Development of a fluorescence polarization based assay for histone deacetylase ligand discovery
- (2008) Ralph Mazitschek et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis
- (2008) Rongbao Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now